AL amyloidosis	systemic light chain amyloidosis
AL-CA	cardiac light chain amyloidosis
ALF	acute liver failure
ALT	alanine aminotransferase (=GPT)
AP	alkaline phosphatase
APRI	AST to platelet ratio index
AST	aspartate aminotransferase (=GOT)
ATTR amyloidosis	transthyretin amyloidosis
ATTR-CA	cardiac transthyretin amyloidosis
AUC	area under the curve
CA	cardiac amyloidosis
COX survival regression	Cox proportional hazard regression
CYP1A2	cytochrome P450 1A2
ECOG Performance Status	Eastern Cooperative Oncology Group Performance Status
eGFR	estimated glomerular filtration rate
FIB-4 (score)	fibrosis-4 (score)
FIB-4clean	fibrosis-4 (score) cleaned for its statistical component related to congestion by regressing the score on NT-proBNP and liver vein congestion
GGT	gamma-glutamyl transferase
GLDH	glutamate dehydrogenase
GLPS	global longitudinal strain
GOT	aspartate aminotransferase (AST)
GPT	alanine aminotransferase (ALT)
HCV	hepatitis C virus
HFpEF	heart failure with preserved ejection fraction
IQR	interquartile range
IQR med	IQR/median
kPA	kilopascal
LASSO	least absolute shrinkage and selection operator regression
LVEF	left ventricular ejection fraction
LSS	Ludwig’s staging system
MAPK pathway	mitogen-activated protein kinase pathway
MBT	13C-methacetin breath test
ML	machine learn
NT-proBNP	N-terminal pro-brain natriuretic peptide
NYHA	New York Heart Association
PBC	primary biliary cholangitis
PDRpeak	maximal percentage of dose rate
PDR20	percentage of dose rate at 20 min
PK model	pharmacokinetic model
posterior wall	left ventricular posterior wall
septum	interventricular septum
TAPSE	tricuspid annular plane systolic excursion
tr-vmax	maximal tricuspid regurgitation velocity
ULN	upper limit of normal
VTCE	vibration-controlled transient elastography
6MWT	6 min walk test